Cargando…

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists

The delta opioid receptor (DOR) is a crucial receptor system that regulates pain, mood, anxiety, and similar mental states. DOR agonists, such as SNC80, and DOR-neutral antagonists, such as naltrindole, were developed to investigate the DOR in vivo and as potential therapeutics for pain and depressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanguturi, Parthasaradhireddy, Pathak, Vibha, Zhang, Sixue, Moukha-Chafiq, Omar, Augelli-Szafran, Corinne E., Streicher, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587863/ https://www.ncbi.nlm.nih.gov/pubmed/34771099 http://dx.doi.org/10.3390/molecules26216693

Ejemplares similares

Correction: Tanguturi et al. Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists. Molecules 2021, 26, 6693
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2022)

The role of opioid receptors in modulating Alzheimer’s Disease
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2023)

Identification of quinazoline compounds as novel potent inhibitors of Wnt/β-catenin signaling in colorectal cancer cells
por: Li, Yonghe, et al.
Publicado: (2016)

Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
por: Gangrade, Abhishek, et al.
Publicado: (2018)

Synthesis and In Vitro Characterization of Glycopeptide Drug Candidates Related to PACAP(1–23)
por: Apostol, Christopher R., et al.
Publicado: (2021)

Parallel Solution-Phase Synthesis and General Biological Activity of a Uridine Antibiotic Analog Library
por: Moukha-chafiq, Omar, et al.
Publicado: (2014)

Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling
por: Archer-Lahlou, Elodie, et al.
Publicado: (2009)

Disque d'or
por: Aznavour, Charles

Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design
por: Zhang, Sixue, et al.
Publicado: (2021)

Les fruits d'or /
por: Sarraute, Nathalie
Publicado: (1963)

Le chercheur d'or /
por: Le Clézio, Jean-Marie Gustave, 1940-
Publicado: (1985)

Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein
por: Yang, Ting, et al.
Publicado: (2008)

Eugeni D'Ors : obra i vida
por: Jardí, Enric
Publicado: (1990)

Les fruits d'or : las frutas de oro
por: Sarraute, Nathalie, 1902-
Publicado: (1965)

Activation of a novel α(2A)AR-spinophilin-cofilin axis determines the effect of α(2) adrenergic drugs on fear memory reconsolidation
por: Saggu, Shalini, et al.
Publicado: (2022)

Generalized Concentration Addition Predicts Joint Effects of Aryl Hydrocarbon Receptor Agonists with Partial Agonists and Competitive Antagonists
por: Howard, Gregory J., et al.
Publicado: (2010)

AM281, Cannabinoid Antagonist/Inverse agonist, Ameliorates Scopolamine-Induced Cognitive Deficit
por: Rabbani, Mohammed, et al.
Publicado: (2012)

Multifunctional Enkephalin Analogs with a New Biological Profile: MOR/DOR Agonism and KOR Antagonism
por: Lee, Yeon Sun, et al.
Publicado: (2021)

Phenotypic analysis of images of zebrafish treated with Alzheimer's γ-secretase inhibitors
por: Arslanova, Dilyara, et al.
Publicado: (2010)

Competitive molecular docking approach for predicting estrogen receptor subtype α agonists and antagonists
por: Ng, Hui Wen, et al.
Publicado: (2014)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
por: Frkic, Rebecca L., et al.
Publicado: (2018)

A single β-octyl glucoside molecule induces HIV-1 Nef dimer formation in the absence of partner protein binding
por: Wu, Mousheng, et al.
Publicado: (2018)

CERN : Le soufre au coeur d'or
Publicado: (1987)

La filosofía de Eugenio d'Ors /
por: Aranguren, José Luis L., 1909-1996
Publicado: (1981)

La filosofía de Eugenio D'Ors
por: Aranguren, José Luis 1909-
Publicado: (1945)

Finale des "Dicos d'or" au CERN
Publicado: (1998)

Dicos d'or: finale départementale au CERN
Publicado: (1998)

Le "rectangle d'or" touche enfin au but
por: Jourdan, Alain
Publicado: (2002)

iOS cloud development dor dummies
por: Goldstein, Neal
Publicado: (2012)

TEE FOR ENDOVENTRICULAR PATCH PLASTY/DOR PROCEDURE
por: Singh, Sarvesh Pal, et al.
Publicado: (2015)

Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor
por: Miura, Shin-ichiro, et al.
Publicado: (2012)

Identification of an irreversible PPARγ antagonist with potent anticancer activity
por: Peng, Youyi, et al.
Publicado: (2020)

QSAR Modeling of Histamine H(3)R Antagonists/inverse Agonists as Future Drugs for Neurodegenerative Diseases
por: Corrêa, Michelle Fidelis, et al.
Publicado: (2018)

CB(1) Allosteric Modulator Org27569 Is an Antagonist/Inverse Agonist of ERK1/2 Signaling
por: Gamage, Thomas F., et al.
Publicado: (2016)

An inverse agonist of orphan receptor GPR61 acts by a G protein-competitive allosteric mechanism
por: Lees, Joshua A., et al.
Publicado: (2023)

Structure and Function of an Irreversible Agonist-β(2) Adrenoceptor complex
por: Rosenbaum, Daniel M., et al.
Publicado: (2011)

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy
por: Go, Eun-Jin, et al.
Publicado: (2020)

Irreversible extreme freezing of gait after dopamine agonist withdrawal
por: Salari, Mehri, et al.
Publicado: (2021)

Correction: Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor
por: Miura, Shin-ichiro, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_juca358pliuoaja7ol1a9ldkuk